Australia markets close in 5 hours 32 minutes

Medivolve Inc. (MEDVF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0130+0.0104 (+400.00%)
At close: 02:42PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 70.25k
Enterprise value 556.78k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.14
Price/book (mrq)0.59
Enterprise value/revenue 0.81
Enterprise value/EBITDA -0.19

Trading information

Stock price history

Beta (5Y monthly) 2.69
52-week change 3-94.74%
S&P500 52-week change 323.10%
52-week high 30.0650
52-week low 30.0010
50-day moving average 30.0125
200-day moving average 30.0227

Share statistics

Avg vol (3-month) 321.08k
Avg vol (10-day) 322.91k
Shares outstanding 527.02M
Implied shares outstanding 685.21M
Float 819.23M
% held by insiders 14.22%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 323 Oct 2015

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-211.23%

Management effectiveness

Return on assets (ttm)-20.13%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)686.45k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-30.10%
Gross profit (ttm)N/A
EBITDA -3.28M
Net income avi to common (ttm)-3.7M
Diluted EPS (ttm)-0.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.01M
Total cash per share (mrq)0.04
Total debt (mrq)1.67M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.08
Book value per share (mrq)-0.58

Cash flow statement

Operating cash flow (ttm)-2.89M
Levered free cash flow (ttm)10.84M